- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Gum Disease.
Displaying page 1 of 1.
EudraCT Number: 2012-002236-87 | Sponsor Protocol Number: RH01561 | Start Date*: 2012-08-16 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||||||||||||||||||
Full Title: Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes | ||||||||||||||||||
Medical condition: Gingival bleeding and gingivitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000260-17 | Sponsor Protocol Number: Intermed_Chlorhexidine_sol_0.2%_ | Start Date*: 2012-09-07 | |||||||||||||||||||||
Sponsor Name:IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.-INTERMED S.A. | |||||||||||||||||||||||
Full Title: A therapeutic equivalence study, comparing two chlorhexidine digluconate formulations, the test formulation Chlorel® Or. T. Sol. 0,2% w / v and the reference formulation Corsodyl® 0.2% w / v Mint M... | |||||||||||||||||||||||
Medical condition: Therapeutic equivalence study, comparing two chlorhexidine digluconate formulations indicated for inhibition of the formation of dental plaque, as an aid in the treatment and prevention of gingivi... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008512-51 | Sponsor Protocol Number: ONE-GLY-P2-01 | Start Date*: 2009-06-09 | |||||||||||
Sponsor Name:onepharm Research & Development GmbH | |||||||||||||
Full Title: A double blind, randomized, placebo-controlled, three-arm, phase II study to investigate the safety and efficacy of oral glycyrrhizin (Glycyron® tablets) for the treatment of gingivitis | |||||||||||||
Medical condition: patients with gingivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003541-15 | Sponsor Protocol Number: 2019-Fungi | Start Date*: 2020-02-19 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: Adjunct effect of fluconazole in the treatment of Candida-associated refractory severe periodontitis – A single-center, placebo-controlled, triple blind, randomized clinical trial | |||||||||||||
Medical condition: Periodontitis. The participants are in good general health, but have at least 2 residual dental lesions after periodontal treatment (standard care). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015914-23 | Sponsor Protocol Number: T3450515 | Start Date*: 2009-12-24 | |||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare (GSKCH) | |||||||||||||
Full Title: Clinical efficacy of an experimental toothpaste | |||||||||||||
Medical condition: Gingivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002708-14 | Sponsor Protocol Number: OML0113 | Start Date*: 2013-10-09 | |||||||||||
Sponsor Name:Schülke & Mayr GmbH | |||||||||||||
Full Title: Phase II study to assess bacterial count reduction of three Octenidine mouthwash concentrations in comparison to a placebo in patients with mild gingivitis | |||||||||||||
Medical condition: patients aged 18 and older with mild gingivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002418-11 | Sponsor Protocol Number: RH01913 | Start Date*: 2013-08-12 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||||||||||||||||||
Full Title: A study to evaluate the effect of a 67% Sodium Bicarbonate containing toothpaste on Chlorhexidine Digluconate tooth staining | ||||||||||||||||||
Medical condition: Tooth discolouration (a labelled undesirable effect of Corsodyl 0.2% mouthwash) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2006-006104-11 | Sponsor Protocol Number: CHX2007-01 | Start Date*: 2008-12-23 |
Sponsor Name:CHX Technologies Europe Ltd. | ||
Full Title: Phase IV Open-label Pharmaco-economic and Practice Management Study of a New Preventive Treatment for Adult Caries in the U.K. and Germany | ||
Medical condition: Adult dental caries | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-005202-19 | Sponsor Protocol Number: DyMZIS-01 | Start Date*: 2017-09-07 |
Sponsor Name:Chemische Fabrik Kreussler & Co. GmbH | ||
Full Title: Multicenter, randomized, split-mouth study to evaluate the acceptance and preference of lidocaine gel compared to injection anesthesia after non surgical periodontal treatment | ||
Medical condition: Moderate parodontitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003385-14 | Sponsor Protocol Number: AROAAT2001 | Start Date*: 2019-08-06 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Placebo-Controlled, Multi-dose, Phase 2/3 Study to Determine the Safety, Tolerability and Effect on Liver Histologic Parameters in Response to ARO-AAT in Patients with Alpha-1 Antitrypsin Deficie... | |||||||||||||
Medical condition: alpha-1 antitrypsin deficiency (AATD)-associated liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) SE (Completed) ES (Restarted) GB (GB - no longer in EU/EEA) PT (Completed) NL (Ongoing) DE (Completed) AT (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000999-11 | Sponsor Protocol Number: MNPR-301-001 | Start Date*: 2021-09-23 | |||||||||||
Sponsor Name:Monopar Therapeutics Inc. | |||||||||||||
Full Title: A Phase 2b/3, multicenter, randomized, double-blind, placebocontrolled study comparing the efficacy and safety of clonidine mucoadhesive buccal tablet to placebo to prevent chemoradiotherapy-induce... | |||||||||||||
Medical condition: Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000068-86 | Sponsor Protocol Number: AROAAT2002 | Start Date*: 2019-07-01 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Pilot Open Label, Multi-dose, Phase 2 Study to Assess the Safety and Efficacy of ARO-AAT in Patients with Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD) | |||||||||||||
Medical condition: alpha-1 antitrypsin deficiency (AATD)-associated liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000917-59 | Sponsor Protocol Number: ARCAAT2001 | Start Date*: 2016-06-29 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals, Inc | |||||||||||||
Full Title: An Open-Label, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Effect on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels of ARC-AAT as evidenced by changes in liver biop... | |||||||||||||
Medical condition: Alpha-1 Antitrypsin Deficiency related liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003467-21 | Sponsor Protocol Number: AROMUC5AC-1001 | Start Date*: 2023-06-07 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 1/2a Study Evaluating the Effects of ARO-MUC5AC Inhalation Solution in Healthy Subjects and Patients with Asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000397-30 | Sponsor Protocol Number: Ponatinib-3001 | Start Date*: 2018-10-23 | |||||||||||
Sponsor Name:Millenium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda pharmaceutical Company Limited) | |||||||||||||
Full Title: A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelp... | |||||||||||||
Medical condition: Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) FI (Completed) BG (Completed) PL (Ongoing) AT (Ongoing) GR (Ongoing) FR (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003313-35 | Sponsor Protocol Number: DCR-A1AT-201 | Start Date*: 2022-01-18 | |||||||||||
Sponsor Name:Dicerna Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients with Alpha-1 ... | |||||||||||||
Medical condition: PiZZAlpha-1 Antitrypsin Deficiency Associated Liver Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Prematurely Ended) NL (Ongoing) PT (Prematurely Ended) BE (Completed) ES (Prematurely Ended) FR (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003466-20 | Sponsor Protocol Number: ARORAGE-1001 | Start Date*: 2023-06-01 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 1/2a Study Evaluating the Effects of ARO-RAGE in Healthy Subjects and Patients with Asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.